ROSEN, A LEADING AND RANKED FIRM, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation – HROW, HROWL, HROWM
March 19, 2023 16:10 ET
|
The Rosen Law Firm PA
NEW YORK, March 19, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Harrow Health,...
ROSEN, A TOP RANKED LAW FIRM, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation – HROW, HROWL, HROWM
March 06, 2023 12:02 ET
|
The Rosen Law Firm PA
NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Harrow Health,...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Harrow Health, Inc. Investors with Losses to Inquire About Securities Class Action Investigation – HROW, HROWL, HROWM
February 28, 2023 16:39 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Harrow Health,...
EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Harrow Health, Inc. Investors to Inquire About Securities Class Action Investigation – HROW, HROWL, HROWM
February 23, 2023 14:49 ET
|
The Rosen Law Firm PA
NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Harrow...
Harrow Health Shareholder News: Johnson Fistel Encourages Harrow Health Shareholders with Losses to Contact the Firm Regarding Class Action Investigation
February 22, 2023 13:27 ET
|
Johnson Fistel, LLP
SAN DIEGO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Harrow Health, Inc. ("Harrow Health" or the "Company") (NASDAQ: HROW), any of...
Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology
June 03, 2021 08:15 ET
|
Visionology
NASHVILLE, Tenn., June 03, 2021 (GLOBE NEWSWIRE) -- Visionology, a subsidiary of Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, today announced that it had acquired a...
Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops
May 17, 2021 09:00 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., May 17, 2021 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business and a wholly owned subsidiary of...
Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
April 20, 2021 16:01 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., April 20, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing of...
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia Journal
December 03, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that a study featuring its patented MKO Melt® formulation has been published in the American...
Harrow Health Announces Participation at the Piper Sandler 32nd Annual Healthcare Conference
November 20, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that Mark Baum, Harrow’s Chief Executive Officer, and Andrew Boll, Harrow’s Chief Financial...